Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kenneth B. Miller, MD
Beth Israel Deaconess Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ccop - Colorado Cancer Research Program, Incorporated
Denver, Colorado, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Lakeside Chicago
Chicago, Illinois, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- Mbccop - Lsu Health Sciences Center
New Orleans, Louisiana, United States
- Tufts - New England Medical Center
Boston, Massachusetts, United States
- Ccop - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
- Ccop - Kalamazoo
Kalamazoo, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Ccop - Southern Nevada Cancer Research Foundation
Las Vegas, Nevada, United States
- Veterans Affairs Medical Center - East Orange
East Orange, New Jersey, United States
- Ccop - Northern New Jersey
Hackensack, New Jersey, United States
- Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Nyu School of Medicine'S Kaplan Comprehensive Cancer Center
New York, New York, United States
- Ccop - Merit Care Hospital
Fargo, North Dakota, United States
- Metrohealth'S Cancer Care Center at Metrohealth Medical Center
Cleveland, Ohio, United States
- Ccop - Columbus
Columbus, Ohio, United States
- Ccop - Geisinger Clinic and Medical Center
Danville, Pennsylvania, United States
- Ccop - Sioux Community Cancer Consortium
Sioux Falls, South Dakota, United States
- Ccop - Scott and White Hospital
Temple, Texas, United States
- Ccop - St. Vincent Hospital Cancer Center, Green Bay
Green Bay, Wisconsin, United States
- Ccop - Marshfield Clinic Research Foundation
Marshfield, Wisconsin, United States
- Medical College of Wisconsin Cancer Center
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Mar 1998
- Primary completion
- 31 Aug 2008
- Completion
- 31 May 2014
- Last update posted
- 29 Jun 2023
- Registered enrollment
- 118
- Registry id
- NCT00003138
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.